TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Sector Chart Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Singapore S.E.
Equities
T14
CNE100000924
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.28 USD | -2.56% |
|
+12.32% | +10.14% |
| 05-15 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Directorate and Committee Changes | CI |
| 04-30 | Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Alternative Medicine
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 6.28B | ||||||
| 4.51B | ||||||
| 3.13B | ||||||
| 2.47B | - | - | - | - | - | |
| 1.96B | - | - |
